🤔 This week: TSLA Q3 earnings report - is now the right time to buy the EV giant?Explore TSLA Data

Peloton teams up with Truemed for HSA/FSA payments

Published 10/10/2024, 09:04 AM
© Reuters
PTON
-

AUSTIN, Texas - In a move to make fitness equipment more accessible, Peloton (NASDAQ: PTON) has partnered with health payment solution provider Truemed. The collaboration announced today allows qualified U.S. customers to purchase Peloton's range of exercise equipment using pre-tax Health Savings Account (HSA) or Flexible Spending Account (FSA) dollars. This new payment option can offer savings of up to 40% on products such as the Peloton Bike, Bike+, Tread, Tread+ and Row.

The initiative is designed to facilitate consumers' investment in their health by simplifying the process of using HSA/FSA funds for fitness-related purchases. Customers at checkout can opt to pay with HSA/FSA funds, complete a brief health survey on Truemed's website, and upon review by a licensed medical provider, receive a Letter of Medical Necessity if eligible. Payments can be made directly using HSA/FSA cards or through reimbursement after using credit or debit cards.

Truemed's CEO Justin Mares emphasized the importance of root-cause interventions in healthcare, highlighting the partnership's potential to enhance consumers' connection to health practices. Greg Hybl, Senior Vice President of Peloton for Business, echoed this sentiment, underlining Peloton's commitment to making fitness accessible and the ease this partnership introduces for customers using pre-tax funds for their wellness.

This partnership aligns with the growing recognition of physical exercise as crucial in managing and preventing chronic health conditions, such as obesity and diabetes. By enabling the use of HSA/FSA funds for fitness equipment, Truemed and Peloton are incentivizing individuals to incorporate exercise into their daily routines as a health intervention strategy.

The collaboration between Truemed and Peloton reflects a shared goal of improving access to fitness and wellness options, leveraging the significant pot of HSA/FSA funds available to qualified Americans. The information is based on a press release statement. For further details on leveraging Truemed HSA/FSA benefits for Peloton products, consumers can visit the Peloton website.

In other recent news, Peloton Interactive (NASDAQ:PTON) has seen several significant developments. The fitness company's stronger-than-anticipated financial performance in its fourth fiscal quarter, including higher revenue and adjusted EBITDA, led to analyst firms Baird and TD Cowen raising their price targets. However, the company's revenue projections for fiscal year 2025 fell slightly short of estimates due to anticipated lower hardware sales.

Peloton is also in the final stages of selecting a new CEO, a strategic effort to steer the company towards a more profitable future. Analysts at JMP Securities project that the incoming CEO may implement a subscription price increase, additional cost reductions, and debt repayment initiatives. Despite a net decrease in paid connected fitness subscribers, Peloton exceeded expectations for paid app subscriptions.

In terms of analyst ratings, BMO Capital Markets and Citi maintained their Market Perform and neutral ratings on Peloton, respectively. These ratings reflect cautious optimism about the company's financial trajectory following its latest restructuring measures. All these are recent developments that underline Peloton's ongoing efforts to enhance profitability and financial health.

InvestingPro Insights

Peloton's partnership with Truemed to enable HSA/FSA purchases aligns with the company's efforts to boost accessibility and potentially drive sales. This move comes at a crucial time for Peloton, as recent InvestingPro data shows the company facing financial challenges.

According to InvestingPro, Peloton's revenue for the last twelve months as of Q4 2023 stood at $2.7 billion, with a slight revenue decline of 3.57% over the same period. This new payment option could help address the sales decline that analysts anticipate for the current year, as noted in one of the InvestingPro Tips.

Despite these challenges, Peloton has shown resilience in the market. InvestingPro data reveals a strong return of 32.58% over the last three months, indicating growing investor confidence. This positive momentum could be further bolstered by initiatives like the Truemed partnership, which aims to make Peloton's products more financially accessible to a broader consumer base.

An InvestingPro Tip highlights that Peloton's liquid assets exceed its short-term obligations, suggesting the company has some financial flexibility to support new initiatives like this partnership. However, another tip cautions that Peloton may have trouble making interest payments on debt, underscoring the importance of strategies to boost sales and improve financial health.

For investors seeking a more comprehensive analysis, InvestingPro offers 11 additional tips for Peloton, providing deeper insights into the company's financial position and market performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.